Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 77
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Tucson, Arizona
  • +131 more
Jul 1, 2022

Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))

Completed
Has Results
  • Lymphoma
  • Multiple Myeloma
  • Muscle Shoals, Alabama
  • +215 more
May 5, 2022

Multiple Myeloma Trial in Germany, Greece (Daratumumab, Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Berlin, Germany
  • +9 more
May 27, 2022

Acute Myelogenous Leukemia, Multiple Myeloma, MDS Trial in Greece, Spain, United States (This is a non-interventional study)

Completed
  • Acute Myelogenous Leukemia
  • +6 more
  • This is a non-interventional study
  • Bakersfield, California
  • +19 more
Apr 4, 2022

Multiple Myeloma, Renal Impairment, Tumors, Plasma Cell Trial in Greece (Isatuximab, Bortezomib, Cyclophosphamide)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Athens, Greece
  • +5 more
Mar 28, 2022

Multiple Myeloma, Renal Impairment, Tumors, Plasma Cell Trial in Greece (Isatuximab, Pomalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Athens, Greece
  • +5 more
Mar 17, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pom/dex (Pomalidomide plus low dose Dexamethasone))

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • Pom/dex (Pomalidomide plus low dose Dexamethasone)
  • Tucson, Arizona
  • +163 more
Feb 25, 2022

Relapse Multiple Myeloma, Multiple Myeloma Trial in Worldwide (Melphalan Flufenamide, Dexamethasone, Daratumumab)

Terminated
  • Relapse Multiple Myeloma
  • Multiple Myeloma
  • Melphalan Flufenamide
  • +2 more
  • Plovdiv, Bulgaria
  • +25 more
Feb 16, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Adelaide, Australia
  • +51 more
Feb 16, 2022

Presentation, Treatment Patterns, and Outcomes in Multiple

Completed
  • Multiple Myeloma
  • No Intervention
  • Little Rock, Arkansas
  • +136 more
Feb 15, 2022

Multiple Myeloma Trial in Worldwide (Teclistamab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Melbourne, Australia
  • +13 more
Feb 7, 2022

Multiple Myeloma Trial in Worldwide (Elotuzumab, Dexamethasone, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +37 more
Jan 14, 2022

Multiple Myeloma Trial in Worldwide (Elotuzumab, Pomalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Atlanta, Georgia
  • +54 more
Jan 11, 2022

Multiple Myeloma, Lymphoma, Amyloidosis Trial in Worldwide (Ixazomib)

Active, not recruiting
  • Multiple Myeloma
  • +2 more
  • Atlanta, Georgia
  • +23 more
Dec 20, 2021

Multiple Myeloma Trial in Worldwide (Pomalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Graz, Austria
  • +111 more
Dec 10, 2021

Multiple Myeloma Trial in Worldwide (Selinexor, Bortezomib, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Plantation, Florida
  • +156 more
Nov 23, 2021

Multiple Myeloma Trial in Worldwide (Pomalidomide and Dexamethasone)

Completed
  • Multiple Myeloma
  • Pomalidomide and Dexamethasone
  • Linz, Austria
  • +21 more
Aug 25, 2021

Multiple Myeloma Trial in Worldwide (Daratumumab, velcade, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Melbourne, Australia
  • +12 more
Aug 25, 2021

COVID-19 Infection and Multiple Myeloma

Recruiting
  • Multiple Myeloma
  • +2 more
    • Vienna, Austria
    • +7 more
    Aug 18, 2021

    4TS RAM in Prevention of Venous Thromboembolism in Plasma Cell

    Recruiting
    • Multiple Myeloma
    • Venous Thromboembolism
    • No intervention
    • Athens, Attica, Greece
      Alexandra Hospital , Department of Clinical Therapeutics
    Apr 27, 2021

    Cardiovascular Complications of Carfilzomib Treatment

    Active, not recruiting
    • Multiple Myeloma
      • Athens, Greece
        Department of Clinical Therapeutics, "Alexandra" General Hospita
      Apr 27, 2021

      Multiple Myeloma Trial in Worldwide (Lenalidomide)

      Completed
      • Multiple Myeloma
      • Baudour, Belgium
      • +72 more
      Apr 13, 2021

      Multiple Myeloma Trial in Worldwide (Bortezomib, Melphalan, Prednisone (VMP), 1 or 2 cycle(s) HDM (High Dose Melphalan), 2

      Active, not recruiting
      • Multiple Myeloma
      • Bortezomib, Melphalan, Prednisone (VMP)
      • +2 more
      • Brisbane, Australia
      • +207 more
      Mar 22, 2021

      Multiple Myeloma Trial in Athens (Belantamab mafodotin)

      Recruiting
      • Multiple Myeloma
      • Belantamab mafodotin
      • Athens, Attica, Greece
        General Hospital of Athens "Alexandra"
      Mar 18, 2021

      Multiple Myeloma Trial in Worldwide (panobinostat capsules, bortezomib injection, dexamethasone tablets)

      Active, not recruiting
      • Multiple Myeloma
      • panobinostat capsules
      • +2 more
      • Fayetteville, Arkansas
      • +79 more
      Mar 15, 2021